Login

Consolidated balance sheets

In millions of USD, except per-share amounts
Q4 FY2016
As of Dec 31, 2016
Q4 FY2015
As of Dec 31, 2015
Q4 FY2014
As of Dec 31, 2014
Q4 FY2013
As of Dec 31, 2013
Q4 FY2012
As of Dec 31, 2012
Q4 FY2011
As of Dec 31, 2011
ASSETS
CURRENT ASSETS:
Cash and cash equivalents
Short-term bank deposits
Short-term marketable securities
Trade receivables, net of allowance for doubtful accounts of $6,173 and $5,223
Deferred tax assets
Other accounts receivable and prepaid expenses
Inventories
Total current assets
LONG-TERM ASSETS:
Long-term deposits and others
Long-term marketable securities
Deferred tax assets, net
Severance pay fund
Investment in Iluminage Beauty
Property and equipment, net
Intangible assets, net
Goodwill
Total long-term assets
Total assets
LIABILITIES AND EQUITY
CURRENT LIABILITIES:
Trade payables
Deferred revenues
Other accounts payable and accrued expenses
Total current liabilities
LONG-TERM LIABILITIES:
Deferred revenues
Warranty accruals
Contingent consideration
Deferred tax liabilities
Accrued severance pay
Total long-term liabilities
Total liabilities
SHAREHOLDERS' EQUITY:
Ordinary shares of NIS 0.01 par value: Authorized - 100,000,000 Ordinary shares; Issued – 38,356,055 and 38,336,805 shares; Outstanding – 34,730,185 and 35,274,577 shares at December 31, 2016 and 2015, respectively
Additional paid-in capital
Treasury shares at cost - 3,625,870 and 3,062,228 Ordinary shares at December 31, 2016 and 2015, respectively
Accumulated other comprehensive loss
Retained earnings
Total shareholders' equity
Total liabilities and shareholders' equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support